Results for virologic translation from English to Maltese

virologic breakthrough
breakthrough viroloġiku

virologic breakthrough**
skoperta 0

virologic non response†
nuqqas ta’ rispons viroloġiku

insufficient virologic response
rispons viroloġiku insuffiċjenti

virologic success at week 48
suċċess viroloġiku f’ġimgħa 48

on- treatment virologic failure
falliment viroloġiku waqt il-kura

lead to loss of virologic response
dan jista’ jwassal għal telf ta’

absence of prior virologic failure
nuqqas ta’ falliment viroloġiku preċedenti

virologic failure and development of resistance
falliment viroloġiku u żvilupp ta’ reżistenza

no virologic data at week 48 or 144 window
l-ebda dejta viroloġika fil- intervall ta’ żmien tal- Ġimgħa 48 jew ta’ 144

total number of virologic failuresa, n (%)
numru totali ta’ fallimenti viroloġiċia, n (%)

baseline genotype or phenotype and virologic outcome
linja bażi ġenotipika jew fenotipika u l-effetti viroloġiċi

one patient had on-treatment virologic failure.
pazjent wieħed kellu falliment viroloġiku waqt il-kura. d.

efficacy was defined as sustained virologic response, rod
effettività kienet iddefinita bħala rispons viroloġiku sostnut, 6 xhur wara t- tmiem tat- trattament.

baseline genotype or phenotype and virologic outcome analyses
analiżi tal-ġenotip jew fenotip tal-linja bażi u riżultat viroloġiku

virologic response of study subjects at week 48 study 802
rispons viroloġiku tal-individwi tal-istudju f’Ġimgħa 48, studju 802

virologic failure (relapse and on-treatment failure)
falliment viroloġiku (rikaduta u falliment waqt il-kura)

intent-to-treat time to loss of virologic response.
ms=mhux stabbilit żmien maħsub għall-għoti tal-kura mqabbel ma’ telf ta’ rispons viroloġiku.

no subjects experienced on-treatment virologic failure or relapse.
l-ebda individwi ma esperjenzaw falliment viroloġiku jew rikaduta waqt il-kura.

c - genotypic etvr with virologic d breakthrough cumulative probability of:
c - etvr ġenotipika bi d breakthrough viroloġika probabbiltà kumuluttiva ta ’: